Dr Oksana FABRI


Contact Information

Dr Oksana FABRI
National Institute of Childrens Diseases
Address:  National Institute of Childrens Diseases, Limbova 1, 83340 Bratislava, Slovakia

Email1: fabri.oksana@gmail.com
Email2: fabri@nudch.eu
Tel:      +421259371692


Current research interests

My research interest lies within the bone marrow failure syndromes both acquired and inherited, including congenital neutropenia and aplastic anaemia. I have also a particular interest in JMML and other rasopathies.


Clinical Expertise related to EuNet-INNOCHRON

Clinical Pediatric Hematology and Oncology particularly bone marrow failure syndromes, autoimmune cytopenias, myeloproliferative-myelodysplastic disorders


Laboratory Epertise related to EuNet-INNOCHRON

  • Flow cytometry of PB and BM

Recent publications related to Eunet-INNOCHRON

  • O. Fábri, J. Horáková, I. Boďová, P. Švec, et al. Diagnosis and treatment of juvenile myelomonocytic leukemia in the Slovak Republic: Novel Approaches. Neoplasma. 2019 Sep;66(5):818-824.doi: 10.4149/neo_2018_181231N1009
  • A. Vaská, M. Makohusová, M. Čermák, K. Plevová, K. Skalická, F. Chovanec, O. Fábri, P. Švec, A. Kolenová Clinical impact of genomic analysis in children with B- Acute lymphoblastic leukaemia: pilot study in Slovakia. Neoplasma. 2019 Nov;66(6):1009-1018. doi: 10.4149/neo_2019_190328N274
  • Kolenova A, Kaiserova E, Makohusova M, Subova Z, Bubanska E, Oravkinova I, Svec P, Fabri O, Hunger SP, Sufliarska S, Horakova S, Mrazova V, Stary J. Improved outcome for children and adolescent with acute lymphoblastic leukemia in the first decade of the 21st century: A report from the Slovak Republic. Neoplasma. 2015;62(5):812-20. doi: 10.4149/neo_2015_098. 
  • Niemeyer CM, Loh ML, Cseh A, Cooper T, Dvorak CC, Chan R, Xicoy B, Germing U, Kojima S, Manabe A, Dworzak M, De Moerloose B, Starý J, Smith OP, Masetti R, Catala A, Bergstraesser E, Ussowicz M, Fabri O, Baruchel A, Cavé H, Zwaan M, Locatelli F, Hasle H, van den Heuvel-Eibrink MM, Flotho C, Yoshimi A. Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia. Haematologica. 2015 Jan;100(1):17-22. doi: 10.3324/haematol.2014.109892.